Literature DB >> 16186633

Allelic association analysis of the functional insertion/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder.

Ivanor Meira-Lima1, Leandro Michelon, Quirino Cordeiro, Hyong Jin Cho, Homero Vallada.   

Abstract

The human serotonin transporter gene (5-HTT) is a candidate for the pathogenesis of mood disorders, including bipolar disorder (BPD). The 5-HTT gene has a 44-bp insertion/deletion polymorphism within the promoter region (5-HTTLPR) with 2 allelic forms, the long (l) and the short (s) variants, which affect transcriptional rates of the 5-HTT gene. Association between the low-activity s variant and BPD has been suggested but remains controversial, as replication has not been consistent. In the present study, we examined the frequency of this polymorphism in a group of 266 Brazilian BPD patients and 306 control subjects. Genotyping for the 5-HTTLPR was performed using PCR. The allele frequencies were found to differ between BPD patients and controls (p=0.03), with a higher frequency of the l allele in the patients compared with the controls (60.5% vs 54.4%). The distribution of genotypes also differed significantly between cases and controls (chi2=10.4, 2 df, p=0.005), with higher frequency of heterozygous l/s genotype in the BPD patient group (52.6% vs 44%). Because prior evidence from gene expression studies indicated that l/s and s/s genotypes are not distinguishable biochemically, we compared the distribution of the l/l genotype and the combined group l/s plus s/s between case and controls, but there was no significant difference (chi2=0.22). Likewise, a logistic regression model considering a dominant role for the s variant was not significant (OR=0.92, 95% CI 0.64-1.32). Our results suggest that the low-activity s variant does not influence susceptibility to BPD in our population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186633     DOI: 10.1385/JMN:27:2:219

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

1.  Analysis of the serotonin transporter polymorphism (5-HTTLPR) in Brazilian patients affected by dysthymia, major depression and bipolar disorder.

Authors:  J R Oliveira; D R Carvalho; D Pontual; R M Gallindo; E B Sougey; V Gentil; B Lafer; L G Maia; M A Morais; S Matioli; H Vallada; R A Moreno; A Nishimura; P A Otto; M R Passos-Bueno; M Zatz
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

Review 2.  Candidate-gene approaches for studying complex genetic traits: practical considerations.

Authors:  Holly K Tabor; Neil J Risch; Richard M Myers
Journal:  Nat Rev Genet       Date:  2002-05       Impact factor: 53.242

3.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

4.  Meta-analysis of serotonin transporter polymorphisms and affective disorders.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Psychiatr Genet       Date:  2004-09       Impact factor: 2.458

Review 5.  Association studies of bipolar disorder.

Authors:  N Craddock; S Davé; J Greening
Journal:  Bipolar Disord       Date:  2001-12       Impact factor: 6.744

6.  Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia.

Authors:  J R Mendes de Oliveira; P A Otto; H Vallada; V Lauriano; H Elkis; B Lafer; L Vasquez; V Gentil; M R Passos-Bueno; M Zatz
Journal:  Am J Med Genet       Date:  1998-05-08

7.  Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.

Authors:  B D Greenberg; T J Tolliver; S J Huang; Q Li; D Bengel; D L Murphy
Journal:  Am J Med Genet       Date:  1999-02-05

8.  An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia.

Authors:  J Ospina-Duque; C Duque; L Carvajal-Carmona; D Ortiz-Barrientos; I Soto; N Pineda; M Cuartas; J Calle; C Lopez; L Ochoa; J Garcia; J Gomez; A Agudelo; M Lozano; G Montoya; A Ospina; M Lopez; A Gallo; A Miranda; L Serna; P Montoya; C Palacio; G Bedoya; M McCarthy; V Reus; N Freimer; A Ruiz-Linares
Journal:  Neurosci Lett       Date:  2000-10-13       Impact factor: 3.046

9.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

10.  Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice.

Authors:  Alena Lira; Mingming Zhou; Nathalie Castanon; Mark S Ansorge; Joshua A Gordon; Jasmine H Francis; Maria Bradley-Moore; Josko Lira; Mark D Underwood; Victoria Arango; Hank F Kung; Myron A Hofer; René Hen; Jay A Gingrich
Journal:  Biol Psychiatry       Date:  2003-11-15       Impact factor: 13.382

View more
  3 in total

1.  Meta-analysis of genetic association studies on bipolar disorder.

Authors:  Fayaz Seifuddin; Pamela Belmonte Mahon; Jennifer Judy; Mehdi Pirooznia; Dubravka Jancic; Jacob Taylor; Fernando S Goes; James B Potash; Peter P Zandi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-09       Impact factor: 3.568

2.  Temporomandibular disorder is associated with a serotonin transporter gene polymorphism in the Japanese population.

Authors:  Kiyomi Ojima; Nagaoki Watanabe; Naoko Narita; Masaaki Narita
Journal:  Biopsychosoc Med       Date:  2007-01-10

3.  Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study.

Authors:  Alicja Sieminska; Krzysztof Buczkowski; Ewa Jassem; Ewa Tkacz
Journal:  BMC Med Genet       Date:  2008-08-08       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.